
Alissa L. Hoey
Examiner (ID: 16643, Phone: (571)272-4985 , Office: P/3765 )
| Most Active Art Unit | 3765 |
| Art Unit(s) | 3765, 3732, 3741 |
| Total Applications | 1846 |
| Issued Applications | 796 |
| Pending Applications | 137 |
| Abandoned Applications | 930 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17741503
[patent_doc_number] => 11389550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound
[patent_app_type] => utility
[patent_app_number] => 16/624946
[patent_app_country] => US
[patent_app_date] => 2018-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13358
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624946
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624946 | Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound | Jun 26, 2018 | Issued |
Array
(
[id] => 16837973
[patent_doc_number] => 20210145985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHOD OF IMAGING IN VIVO TISSUES USING NANOPARTICLES COMPRISING A REFERENCE DYE AND A SENSOR DYE
[patent_app_type] => utility
[patent_app_number] => 16/624358
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624358 | METHOD OF IMAGING IN VIVO TISSUES USING NANOPARTICLES COMPRISING A REFERENCE DYE AND A SENSOR DYE | Jun 21, 2018 | Abandoned |
Array
(
[id] => 13618823
[patent_doc_number] => 20180360963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => NEUTRON CAPTURE THERAPY SYSTEM FOR ELIMINATING AMYLOID ss-PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/010818
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010818 | Neutron capture therapy system for eliminating amyloid b-protein | Jun 17, 2018 | Issued |
Array
(
[id] => 17974407
[patent_doc_number] => 11491244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Labeled fluorocarbon agents for positron emission tomography imaging
[patent_app_type] => utility
[patent_app_number] => 16/618145
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8257
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618145 | Labeled fluorocarbon agents for positron emission tomography imaging | Jun 3, 2018 | Issued |
Array
(
[id] => 13586667
[patent_doc_number] => 20180344882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => NOVEL DEUTERIUM SUBSTITUTED POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS AND THEIR PHARMACOLOGICAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 15/994474
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994474
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994474 | Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application | May 30, 2018 | Issued |
Array
(
[id] => 14018871
[patent_doc_number] => 20190071429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => MULTIPLE-FUNCTIONAL PROBE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/988344
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988344
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/988344 | MULTIPLE-FUNCTIONAL PROBE AND USES THEREOF | May 23, 2018 | Abandoned |
Array
(
[id] => 15678557
[patent_doc_number] => 20200093942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => NEAR-INFRARED CHEMILUMINESCENT PROBES FOR IN-VIVO IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/616336
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616336 | Near-infrared chemiluminescent probes for in-vivo imaging | May 22, 2018 | Issued |
Array
(
[id] => 13563917
[patent_doc_number] => 20180333506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => SYSTEMS AND METHODS FOR MINIMALLY-INVASIVE ASSESSMENT OF TOXICITY-INDUCED TISSUE INJURY
[patent_app_type] => utility
[patent_app_number] => 15/981568
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981568
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/981568 | Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury | May 15, 2018 | Issued |
Array
(
[id] => 18962942
[patent_doc_number] => 11896681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Particles comprising bilirubin derivative and metal
[patent_app_type] => utility
[patent_app_number] => 16/343043
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 40
[patent_no_of_words] => 12057
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343043
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343043 | Particles comprising bilirubin derivative and metal | May 13, 2018 | Issued |
Array
(
[id] => 16087119
[patent_doc_number] => 20200197546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => USE OF ANTI-B7H3 ANTIBODIES FOR TREATING CANCER IN THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/613028
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613028 | USE OF ANTI-B7H3 ANTIBODIES FOR TREATING CANCER IN THE CENTRAL NERVOUS SYSTEM | May 13, 2018 | Abandoned |
Array
(
[id] => 15160827
[patent_doc_number] => 10485886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Core-satellite nanocomposites for MRI and photothermal therapy
[patent_app_type] => utility
[patent_app_number] => 15/972674
[patent_app_country] => US
[patent_app_date] => 2018-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 11256
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15972674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/972674 | Core-satellite nanocomposites for MRI and photothermal therapy | May 6, 2018 | Issued |
Array
(
[id] => 13533815
[patent_doc_number] => 20180318450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => ENHANCED SURGICAL VISUALIZATION OF VIABLE TISSUE WITH SELECTIVE DYE
[patent_app_type] => utility
[patent_app_number] => 15/969399
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15969399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/969399 | ENHANCED SURGICAL VISUALIZATION OF VIABLE TISSUE WITH SELECTIVE DYE | May 1, 2018 | Abandoned |
Array
(
[id] => 16893458
[patent_doc_number] => 11034994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => In vivo detection of phospholipase activation
[patent_app_type] => utility
[patent_app_number] => 15/967216
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 19635
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15967216
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/967216 | In vivo detection of phospholipase activation | Apr 29, 2018 | Issued |
Array
(
[id] => 16297809
[patent_doc_number] => 20200283532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => TUMOUR-TARGETING PEPTIDE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 16/607337
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607337 | TUMOUR-TARGETING PEPTIDE VARIANTS | Apr 23, 2018 | Abandoned |
Array
(
[id] => 16060967
[patent_doc_number] => 10689415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers
[patent_app_type] => utility
[patent_app_number] => 15/957343
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 82
[patent_no_of_words] => 34421
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 649
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/957343 | Conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers | Apr 18, 2018 | Issued |
Array
(
[id] => 18642430
[patent_doc_number] => 11766483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Compounds and therapeutics uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/603579
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 38
[patent_no_of_words] => 25349
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603579
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603579 | Compounds and therapeutics uses thereof | Apr 5, 2018 | Issued |
Array
(
[id] => 16718661
[patent_doc_number] => 20210085808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/499070
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499070
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/499070 | Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer | Mar 29, 2018 | Issued |
Array
(
[id] => 14116771
[patent_doc_number] => 10245226
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => Method for preventing nasolacrimal duct obstruction
[patent_app_type] => utility
[patent_app_number] => 15/925260
[patent_app_country] => US
[patent_app_date] => 2018-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2782
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15925260
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/925260 | Method for preventing nasolacrimal duct obstruction | Mar 18, 2018 | Issued |
Array
(
[id] => 13302799
[patent_doc_number] => 20180202936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => Modified Hydrocyanine Dyes for the Detection of Reactive Oxygen Species
[patent_app_type] => utility
[patent_app_number] => 15/923262
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923262
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923262 | Modified Hydrocyanine Dyes for the Detection of Reactive Oxygen Species | Mar 15, 2018 | Abandoned |
Array
(
[id] => 17235620
[patent_doc_number] => 11179483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Per-oral negative contrast agent for abdominal CT
[patent_app_type] => utility
[patent_app_number] => 16/489063
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 18683
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489063
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489063 | Per-oral negative contrast agent for abdominal CT | Feb 25, 2018 | Issued |